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Proepicardial cells give rise to epicardium, coronary vasculature and cardiac fibroblasts. The proepicardium is derived from the mesodermal
lining of the prospective pericardial cavity that simultaneously contributes myocardium to the venous pole of the elongating primitive heart tube.
Using proepicardial explant cultures, we show that proepicardial cells have the potential to differentiate into cardiac muscle cells, reflecting the
multipotency of this pericardial mesoderm. The differentiation into the myocardial or epicardial lineage is mediated by the cooperative action of
BMP and FGF signaling. BMP2 is expressed in the distal IFT myocardium and stimulates cardiomyocyte formation. FGF2 is expressed in the
proepicardium and stimulates differentiation into the epicardial lineage. In the base of the proepicardium, coexpression of BMP2 and FGF2
inhibits both myocardial and epicardial differentiation. We conclude that the epicardial/myocardial lineage decisions are mediated by an extrinsic,
inductive mechanism, which is determined by the position of the cells in the pericardial mesoderm.
© 2006 Elsevier Inc. All rights reserved.Keywords: Cardiovascular development; Proepicardium; Cardiomyogenesis; Cell lineage; Bone morphogenetic protein; Fibroblast growth factor; ChickenIntroduction
The embryonic heart tube is formed by fusion of the
primary heart fields (Rosenquist and de Haan, 1966; Stalsberg
and DeHaan, 1969) and comprises an outer myocardial layer
and an inner endocardial layer. As development proceeds,
myocardium is added to the posterior and anterior sides of the
tube forming the inflow and outflow region, respectively
(reviewed in Buckingham et al., 2005; Kelly, 2005; van den
Hoff et al., 2004). The addition to the inflow is considered to
be a continuous addition of myocardium from the primary
heart fields, whereas the myocardium added to the outflow
has been suggested to be derived from a distinct heart-
forming field, referred to as the anterior or secondary heart⁎ Corresponding author. Fax: +31 20 6976177.
E-mail address: m.j.vandenhoff@amc.uva.nl (M.J.B. van den Hoff).
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doi:10.1016/j.ydbio.2006.03.033field (Kelly et al., 2001; Mjaatvedt et al., 2001; Waldo et al.,
2001). Recent studies suggest, however, that myocardial
precursor cells added to the anterior and posterior poles of the
linear heart tube are derived from the same pool of precursor
cells (Cai et al., 2003; Kelly, 2005; Meilhac et al., 2004),
which is referred to as the second lineage and is located
medially and dorsally to the cardiac crescent, which
encompasses the pool of precursor cells forming the primary
heart tube, i.e., the first lineage (Cai et al., 2003; Meilhac et
al., 2004). Recent advances have shown that the combined
action of bone morphogenetic proteins (BMPs) and fibroblast
growth factors (FGFs) play a crucial role in the differentiation
of cardiogenic mesoderm into the myocardial lineage
(reviewed in Brand, 2003).
Concomitant with ongoing myocardium formation in
vertebrates, including man, a subpopulation of mesothelial
cells adjacent to the inflow tract (IFT) myocardium proliferates
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cavity. This cluster of villous outgrowths, which contains
numerous mesenchymal cells, is called the proepicardium and
provides the precursors for several non-myocardial lineages
within the heart including the epicardium, coronary smooth
muscle cells, coronary endothelium and cardiac fibroblasts
(reviewed in Munoz-Chapuli et al., 2002; Wessels and Perez-
Pomares, 2004).
The molecular mechanisms underlying the formation of the
proepicardium and the IFT myocardium from progenitor cells in
the flanking pericardial mesoderm are largely unknown. In this
study, we investigated whether the potential to form myocar-
dium is retained in the formed proepicardium, epicardium and
subepicardial mesenchyme. Secondly, we investigated the
potential function of BMP and FGF in regulating the
recruitment of these progenitor cells to the proepicardium and
to the myocardium.
We show that cells of the chicken proepicardium are not
irreversibly committed to the epicardial lineage but instead are
able to spontaneously differentiate into cardiac muscle cells in
vitro. This makes the proepicardial cultures a unique model to
study the conditions that favor differentiation towards the
myocardial or epicardial lineage. Our data suggest the
existence of 3 distinct zones at the inflow tract of the heart:
(1) the myocardial differentiation zone, which extends from
the most distal IFT myocardium to the proepicardium. In this
zone, pericardial mesodermal cells differentiate into cardio-
myocytes under the control of BMP2, BMP4 and FGF8; (2)
the proepicardial differentiation zone, which comprises the
proepicardium proper. In this zone, pericardial mesodermal
cells are recruited into the epicardial lineage under the control
of FGF2 and, possibly BMP4; (3) the transition zone, which
is located between the two other zones, i.e., the pericardial
mesoderm below the proepicardium and adjacent to the IFT
myocardium. In this transition zone, the cells are prevented
from undergoing myocardial differentiation or recruitment
into the epicardial lineage by the combined action of BMP2
and FGF2.Materials and methods
Chicken embryos
Fertilized chicken eggs were obtained from a local hatchery (Drost BV,
Nieuw Loosdrecht, The Netherlands), incubated at 39°C in a moist
atmosphere, and automatically turned every hour. After the appropriate
incubation times, embryos were isolated in Earl's balanced salt solution
(EBBS, Life Technologies) and staged according to Hamburger and Hamilton
(Hamburger and Hamilton, 1951). Embryos used for whole-mount immunos-
taining were fixed in DMSO:methanol (1:4), for in situ hybridization in
freshly prepared 4% (w/v) paraformaldehyde (PFA) in PBS, and for
immunostaining on sections in methanol:acetone:water (2:2:1), or 4% PFA.
Embryos used for sections were dehydrated in a graded alcohol series and
embedded in paraplast.
In vitro explant assay and immunostaining
Collagen gels were prepared according to procedures previously described
(van den Hoff et al., 2001). After isolation of HH16–17 embryos, proepicardiawith extensive villous processes but no firm attachments to the heart tube were
carefully cut at their base (see Fig. 1bʺ) to avoid inclusion of liver primordium
or sinus venosus and positioned on top of a drained collagen gel. After
overnight incubation to allow proper attachment to the gel, complete M199
medium (M199 medium containing penicillin/streptomycin (Life Technolo-
gies), 5 μg/ml insulin, 5 μg/ml transferrin and 5 ng/ml selenium (ITS,
Collaborative Research Inc.), 2 mM glutamine (Life Technologies), and 1%
chicken serum) was added. Recombinant human BMP2, BMP4 (Genetics
Institutes), BMP5 (R&D), FGF2, FGF4, FGF8, FGF10 (Peprotech), recom-
binant mouse noggin (R&D), SU4984, SU5402 (Calbiochem), or Bromo-
deoxyuridin (Sigma) was added individually or in combination to the medium
to a final concentration of 50 ng/ml or as indicated. All explants were cultured
up to 5 days (37°C, 5% CO2,) prior to fixation.
To establish epicardial cell cultures, chicken hearts of HH25 or HH36 were
placed on collagen gels. During overnight incubation, epicardial monolayers
formed on the surface of the collagen gels. After this overnight incubation, the
hearts were removed, and complete M199 medium was added. The culture was
maintained for a total of 5 days. To study epicardium formation, proepicardia
were put on an agar layer (1%) against the outer myocardial side of an apex of a
ventricle or a sinus venosus of an HH16 embryo and cultured in complete M199
medium for 1 day.
To enable immunohistochemical staining of non-attaching proepicardia,
cardiac explants, or proepicardia directly after isolation, the explants were
positioned on a gel and overlaid with a thin agarose layer (1%; Sigma). An
HH16 OFT was included as positive control for the immunostaining.
The gels containing the explants were fixed and immunofluorescently stained
as described (Kruithof et al., 2003b).
Fixed whole-mount embryos were hydrated in methanol series,
permeabilized with 1% Triton-X100 (v/v) and blocked with PENG (PBS,
5 mmol/l EDTA, 150 mmol/l NaCl, 0.25% (w/v) gelatin). Sections used for
immunofluorescent staining were hydrated and incubated with TENG-T
(10 mmol/l Tris, 5 mmol/l EDTA, 150 mmol/l NaCl, 0.25% (w/v) gelatin
and 0.05% (v/v) Tween-20, pH 8.0). Primary antibodies were applied
overnight. After extensive washing with PBS, cultures, whole mounts and
sections were incubated with fluorescent secondary antibodies (Alexa
conjugates; Molecular Probes).
As primary antibodies MF20 (Hybridoma bank, Iowa City, IA, USA),
sarco-endoplasmatic reticulum Ca2+ ATPase (SERCA2a; kindly provided
by Dr. F. Wuytack (Eggermont et al., 1990)), myosin light chain 2v
(MLC2v; kindly provided by Dr. W. Franz; Lübeck, Germany; (Katus et
al., 1982), myosin heavy chain (MHC (169-II-A2); (Wessels et al., 1991),
and cardiac Troponin I (cTnI, HyTest, 4T21/2, Breda, The Netherlands)
were used to identify myocytes, γSMA (ICN; clone B4, Costa Mesa, CA,
USA) to identify smooth muscle cells, pan-cytokeratin (Z0622, DAKO) to
identify pericardial mesoderm and proepicardium, and anti-BrdU (anti-
BrdU pure; BD Biosciences, Alphen aan den Rijn, The Netherlands) to
identify incorporated BrdU. Phalloidin–Texas red conjugate (Molecular
Probes) was used to visualize all cells in the cultures and propidium
iodine (Sigma) or Sytox64 (Molecular Probes) to visualize the nuclei.
Fluorescence in the embryos, explants or sections visualized using
confocal laser scanning microscopy (Biorad MRC1024). Non-immunoflu-
orescent MF20 staining on sections was performed as previously described
(Kruithof et al., 2003b).
The total area of myocytes in the proepicardial explant culture was
determined using a user-written macro in NIH-image (version 1.62). Only
proepicardial explants that showed monolayer formation after the first overnight
incubation were included for further analysis. In the analysis of the data, factor
correction is applied to remove multiplicative between-session variation in
experiments (Ruijter et al., 2006).
Fluorescent labeling of the proepicardium
Approximately 2 μl of a 1/50 dilution of the stock solution of CCFSE
(5,6-carboxy-2′,7′dichloro fluorescein diacetate succinimidyl ester, Molecular
Probes; 6.26 mg/ml in DMSO) in Pannet-Compton saline (Stern and Holland,
1993) were injected into the pericardial cavity of chicken embryos from
stages HH16–17. After a reincubation for 3 h, the proepicardia were carefully
excised, extensively washed in EBSS and cultured on collagen gels in M199
Fig. 1. Overlapping gradients of gene expression suggest that pericardial mesoderm is a common source for IFT myocardium and proepicardium. Whole-mount
(a, b) or sections (c–k) of HH16–17 chicken embryos were stained for cytokeratin expression (red, a–d, i–k), MF20 (green; a–d, f) or SERCA2a expression
(green; g, h, j, k). Panels a, b are merged images of a′, aʺ and b′, bʺ. Panels a and b show decreased myosin expression (green) towards the distal ends of the
heart tube (arrow in b′) and cytokeratin expression (red) that tapers off in the myocardium at the distal borders of the heart (arrow in b″). The dotted line in panel
b″ indicates the cutting edge for the isolation of the proepicardium that were used in the in vitro assay. Colocalization of MF20 and cytokeratin (yellow and
arrow) is evident at the inflow tract of the heart as shown in panels c and d. In situ hybridization (e) and immunohistochemistry (f) showed no detectable VMHC
mRNA or MHC proteins (MF20 staining), respectively, in the proepicardium in vivo. Panels g–i show neighboring sections that are immunofluorescently stained
for SERCA2a (g, h) and cytokeratin (i). SERCA2a is expressed at high levels in the IFT myocardium and at low levels in the base of the cytokeratin-expressing
proepicardium and adjacent mesoderm. Note that virtually no expression of SERCA2a was observed in the top part of the proepicardium (arrow in h), which did
express cytokeratin (arrow in i). Panels j and k show a section through the proepicardium that was triple immunofluorescently stained for SERCA2a (green),
cytokeratin (red) and the nuclear marker Syto64 (blue). Note the low level SERCA2a staining in the cytokeratin-expressing cells in the base of the proepicardium
(arrows in k). In panel l a schematic diagram of the proepicardial region is shown in which the myocardial marker SERCA2a is depicted in green and pericardial/
epicardial marker cytokeratin in red. Coexpression of the myocardial and pericardial/epicardial marker in the base of the proepicardium suggests that a common
pool of pericardial mesodermal cells contributes to both the IFT myocardium and proepicardium. Abbreviations: inflow tract, IFT; PE, proepicardium; V,
ventricle. Scale bar in panels a–j: 200 μm and in k: 100 μm.
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4% formaldehyde. Colocalization of CCFSE-labeled cells and the MF20-
antigen was performed by immunostaining using the MF20 antibody.
Non-radioactive in situ hybridization on sections
The in situ hybridization procedure and the probes used were recently
described (Somi et al., 2004a,b).RNA extraction, cDNA synthesis and PCR
RNA extraction from HH16 embryonic heart or proepicardium, cDNA
synthesis and PCR were performed as previously described (Kruithof-de
Julio et al., 2005) using the following primers: fibroblast growth factor
(FGF) 2 (S: 5′-GAGAGAGGAGGTTGTGTC-3′ and A: 5′-CGTTT-
CAGTGCCACATA-3′) and FGF4 (S: 5′-CAGTCTAGGAAGGAAGTG-3′
and A: 5′-CCGACGAGTGTAAATTCA-3′).
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Expression patterns suggest contribution of pericardial
mesoderm to the proepicardium and inflow tract myocardium
Lineage studies (Cai et al., 2003; Meilhac et al., 2004),
morphological and immunohistological analyses (Kruithof et
al., 2003a; Viragh and Challice, 1973) have shown the
addition of myocardium to the inflow tract of the heart from
the pericardial mesoderm contributing to the atrial appendage
myocardium, to smooth-walled dorsal atrial myocardium, and
to the caval myocardium (van den Hoff et al., 2004). To
study this myocardium formation, whole-mount chicken
embryos of HH stage 16 were double immunostained for
cytokeratin, which is expressed by the pericardial mesoderm
(Pérez-Pomares et al., 1998; Vrancken Peeters et al., 1995)
and for the myocardial marker MF20 (Fig. 1). Cytokeratin
staining was observed in the pericardial mesoderm, the
proepicardium and in the IFT myocardium in which it tapers
off (arrow in Fig. 1b″). MF20 staining is present in the
myocardium of the heart, in the immediate adjacent
pericardial mesoderm in which it tapers off (arrow in Fig.
1b′), and absent from the proepicardium proper (Fig. 1b′).
Immunofluorescent staining on sections showed colocaliza-
tion of cytokeratin and myosin heavy chain expression in the
cells of the distal IFT myocardium (Figs. 1c, d). Using the
antibody directed against the myocardial marker sarco-
endoplasmatic reticulum Ca2+ ATPase (SERCA) 2a, we
observed a similar, but slightly broader expression pattern,
than we observed for MF20 staining, extending into the
mesodermal cells below the proepicardium (Figs. 1g, h). The
distal portion of the proepicardium does not express
detectable levels of SERCA2a (arrow in Fig. 1h). Double
immunofluorescent staining using cytokeratin and SERCA2a
also showed that the mesodermal cells adjacent to the inflow
tract myocardium coexpressed both markers (Figs. 1j, k).
Taken together, these observed reciprocal expression gradi-
ents of pericardial/epicardial (cytokeratin) and myocardial
(MF20 and SERCA2a) markers, together with their coloca-
lization at the cellular level, suggest the contribution of the
pericardial mesoderm to the proepicardium and IFT myocar-
dium (Fig. 1l).
Proepicardial cells differentiate spontaneously into cardiac
muscle cells
Although cells of the proper proepicardium do not express
myocardial markers in vivo (Figs. 1b′, e–h, j), explant cultures
of proepicardia derived of HH16–17 chicken embryos often
showed a spontaneously rhythmically contracting area after
5 days of culture, suggesting the presence of cardiomyocytes.
The presence of cardiomyocytes was confirmed by immuno-
fluorescent staining of these cultures using antisera directed
against cardiac proteins (MF20 Fig. 2d′, βMHC, MLC2v or
SERCA2a (not shown)).
The presence of the cardiomyocytes in these explant
cultures might be due to contamination of the closely adjacentIFT myocardium or due to differentiation of the proepicardial
cells during the culture. To address this issue, we fixed
proepicardia directly after isolation and assessed for MF20-
positive cells. In 40 out of 51 proepicardia (∼80%), no
MF20-positive cells were observed (Figs. 2a′,e), whereas after
5 days of culture, a large field of MF20-positive cells was
present in all 143 analyzed explant cultures (Figs. 2d′, e).
These findings indicate that differentiation rather than
contamination attributed to the presence of myocardium in
the cultured proepicardia.
BrdU had previously been shown to block myocardial
differentiation but not the proliferation of already formed
cardiomyocytes (Chacko and Joseph, 1974; Montgomery et
al., 1994). Proepicardial cultures exposed to BrdU from the
start of the culture showed the presence of BrdU in all
nuclei but no formation of myocardial cells (Fig. 2k). These
results support our conclusion that myocardial cells found in
the explant cultures are the result of differentiation from
non-myocardial cells, rather than from proliferation of
contaminating cells. To minimize the probability of any
potential myocardial contamination from the IFT myocardi-
um, proepicardial cultures displaying contractions after 1 day
of culture were discarded and refrained from further
analyses.
The proepicardium consist of a mesothelial lining that
surrounds a mesenchymal core (Pérez-Pomares et al., 1998). To
investigate whether the mesothelial lining is able to differentiate
into myocardium, the mesothelial lining was fluorescently
labeled in ovo (Fig. 2f). Subsequently, the proepicardia were
isolated and cultured for 1 day. Upon fixation and staining, a
subset (about 20%) of the fluorescently labeled mesothelial cells
was found to stain for MF20 as well (Fig. 2g), showing that
mesothelial cells lining the proepicardium are able to differen-
tiate into heart muscle cells in vitro.
In precardiac mesoderm explant cultures, distinct stages of
myosin assembly and association of myosin-positive cells are
considered a characteristic of myocardial differentiation
(Eisenberg and Eisenberg, 1999; Rudy et al., 2001). To
investigate whether these distinctive changes are also
observed in proepicardial cultures, explants were fixed at
different time points. One day after being explanted,
proepicardial cultures showed small clusters of myocytes
and individual myocytes with diffuse myosin staining in the
cytoplasma (Figs. 2b′, h), which is characteristic of early
myocardial differentiation (Han et al., 1992). After 3 days,
several larger clusters of myocytes were present in these
cultures (Fig. 2c′) displaying an immature myosin organiza-
tion as apparent from diffuse and/or dotted myosin staining
(Fig 2i). After 5 days, one large myosin-positive field of cells
was generally observed (Fig. 2d′). These fields were
multilayered and comprised mostly elongated and aligned
myocytes in the center, which contained linearly organized
myosin (Fig. 2j). Cardiomyocytes with immature myosin
organization were observed around the multilayered myocar-
dial center. These observations support the previous conclu-
sion that proepicardial cells are able to differentiate into
myocardium in vitro.
Fig. 2. Proepicardial cells have the potential to differentiate into myocardial cells in vitro. Bright-field images of characteristic examples of a proepicardial explant
directly after isolation (a) and after 1, 3, and 5 days of culture (b–d). These cultures were stained using MF20 (green; a′–d′) to identify the myocytes. Propidium iodine
was used to identify the nuclei (red; a′–d′, g, h–j). Panel e shows a summary of the occurrence of myocardium in proepicardial cultures after different culture periods.
Panel f shows a section through the proepicardium of an embryo in which the mesothelial cells flanking the pericardial cavity were labeled with CCFSE (green). MF20
staining (blue) after 1 day of culture of CCFSE-labeled proepicardia showed that a subset (about 20%) of the mesothelial cells (green) is able to differentiate into
MF20-positive myocytes (arrow in g). The intracellular staining pattern of myosin underscores de novo differentiation of myocytes, because after 1 day of culture, the
myosin staining is diffuse in the cytoplasma (h), is dotted after 3 days of culture (i), and is linearly organized after 5 days of culture (j). In line with this notion, we
observed that culturing proepicardia in the presence of BrdU blocked the formation of myocyte formation completely, as assessed by MF20 staining (not shown) or
cTnI staining (red; k). Costaining of these cultures for the presence of BrdU showed staining in virtually all nuclei (green). Scale bar in panels a–d, f, g is 200 μm, in
panel g 50 μm, and in panels h–j 400 μm.
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differentiation in proepicardium
Next, we investigated whether a population of mesodermal
cells in the proepicardial explants is already specified to the
myocardial lineage by culturing them under serum-free
conditions. In the absence of serum, most of the proepicardia
failed to attach properly to the collagen gel and floated in the
medium (∼80%; Fig. 3a). After 3 days of culture, however,
the floating proepicardial aggregates started to display
rhythmic contractions, suggesting the presence of cardiac
muscle cells. After 7 days of culture, the presence of cardiac
muscle cells in these aggregates was confirmed by immuno-
fluorescent staining (Fig. 3a′). If the proepicardium did attach
to the collagen gel, two options appeared possible. In the firstgroup, no mesenchymal cells were formed in the collagen gel
(Fig. 3b), but cardiac muscle cells were formed, similar to the
serum-containing cultures in a multilayered region of the
explant, which often displayed beating activity (Fig. 3b′). In
the other group, a monolayer was formed without a multi-
layered region (Fig. 3c), containing a few scattered non-
beating MF20-positve cells (Fig. 3c′). The latter observation
suggests that aggregation is required for full differentiation
into cardiomyocytes. The spontaneous differentiation of
proepicardial cells into cardiac muscle cells under serum-
free conditions indicates that at least a subset of the
proepicardial cells is specified to the myocardial lineage in
vivo. We, therefore, infer that active inhibition of myocardial
differentiation is required to prevent myocardial differentia-
tion in the proepicardium.
Fig. 3. Characteristic examples of myocardial differentiation in proepicardial cultures using different culture conditions. Panels a–h show bright field images, whereas
panels a′–h′ showMF20 (green) and propidium iodine (red) staining of the respective cultures. Panel a–d show proepicardia that were cultured in the absence of serum
and ITS. Proepicardia that detached from the collagen were found to express MF20 (a′). If proepicardia attached to the collagen two options were possible, either a
multilayered MF20-positive center was formed (b′) or a monolayer was formed, in which some scattered MF20-positive cells were present (c′). Addition of BMP2 to
these cultures induced myocardium formation in the monolayer (d). Panels e–h show proepicardia that were cultured in the presence of 1% chicken serum and ITS.
Addition of both BMP2 and BMP4 resulted in extensive myocardium formation (e). When proepicardia were cultured on BMP2 conditioned gels, most of the cells
were found to express MF20 (f). When proepicardia were cultured on gels conditioned with BMP2 and FGF2, myocardium formation was blocked (g). Culturing
proepicardia in the presence of the FGFR-1 inhibitor SU5402 (50 μM) showed less outgrowth of the explants and severely reduced mesenchyme formation (h), but
myocardium was formed (h′). Scale bar is 200 μm.
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spontaneously into cardiac muscle cells
In vivo experiments analyzing the fate of the proepicardial
cells have never identified a contribution to the myocardial
lineage (Manner, 1999), suggesting that throughout develop-
ment, myocardial differentiation is actively inhibited in the
derivatives of the proepicardium or that the capacity to
differentiate into heart muscle cells is lost. To discriminate
these two options, we established epicardial cell cultures of
HH25 or HH36 chicken hearts and maintained these under
similar conditions as the proepicardial cultures. After 5 days
of culture, beating areas were never observed and upon
immunofluorescent staining very few, if any, MF20-positive
cells were observed (data not shown). These observationssuggest that the ability to spontaneously differentiate into
cardiomyocytes is lost in proepicardial derivatives.
γSMA expression and mesenchyme formation indicate
differentiation into the epicardial lineage
To assess differentiation of proepicardial cells into the
epicardial lineages in our explant cultures, we examined smooth
muscle marker expression using an antiserum directed against
γ−Smooth Muscle Actin (γSMA) (Landerholm et al., 1999;
Wada et al., 2003) and the formation of mesenchyme in the gel
using phalloidin (Dettman et al., 1998; Morabito et al., 2001).
The formation of mesenchyme in the collagen gel is reminiscent
of the invasion of the nascent proepicardium by mesothelium-
derived mesenchymal cells (Pérez-Pomares et al., 1998) and the
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subepicardial space (Dettman et al., 1998; Morabito et al.,
2001). Staining of proepicardial cultures for γSMA identified a
gradient in its expression (Figs. 4a, b); with no expression in the
center of the proepicardial culture (#1 in Figs. 4a, b), high levels
of expression in cells that have detached from the edge of the
epithelial sheet (#3 in Figs. 4a, b, and c), and low levels of
expression in the remainder of the cells (#2 in Figs. 4a, b). InFig. 4. BMP- and FGF-mediated epicardial differentiation in proepicardial cultures.
using gamma SmoothMuscle Actin (γSMA) expression (a–g). In control proepicardia
the boxed area shown in panel a. Three levels of γSMA can be discriminated. At the b
the collagen gel expressed the highest levels of γSMA (referred to as zone 3). In the c
was found. In between these two zones, cells expressing intermediate levels of γSM
explant is shown (zone 3) showing on top of the collagen gel cells that express high le
general, express low levels of γSMA expression (arrow in panel d). Culturing proep
whereas BMP4 plus FGF4 (g) stimulated γSMA expression. Panel h depicts a
proepicardium-derived cells are exposed to FGF4 in the myocardium, possibly guid
proepicardial explants of the same magnification stained with propidium iodine (i, j) a
controls (i), the FGFRI inhibitor (j) inhibited growth, whereas FGF2 (k) or BMP2 and
present in the collagen gel are visualized in control and FGF2-stimulated cultures, sho
and to BMP2 and FGF2 treated explants (not shown). Panel o summarizes the exten
from the start of the culture using the following arbitrary scoring scale: 1: no mesen
mesenchyme formation in the gel; 4: extensive mesenchyme formation in the collagen
of growth by FGF2 (k, l), BMP2 neutralized mesenchyme formation stimulated by FG
c, d, 25 μm.addition, we observed that a subset of mesenchymal cells in the
collagen gel expressed low levels of γSMA (Fig. 4d).
Members of the BMP and FGF families are expressed in the
proepicardial region
The observations that proepicardial cells are capable to
differentiate into the myocardial and epicardial lineages raisesSmooth muscle cell formation, suggestive of epicardial formation, was assessed
l explants different levels of γSMA expression were observed (a). Panel b shows
order of the explant cells that had dislodged from the epithelial context on top of
enter of the cultures, a small area (referred to as zone 1) of γSMA-negative cells
A (referred to as zone 2) are present. In panels c and d, the border of a control
vels of γSMA-expressing (c) and in the collagen gel, mesenchymal cells that, in
icardia in the presence of Noggin (e) or FGF2 (f) inhibited γSMA expression,
schematic model of smooth muscle cell differentiation. BMP4-expressing
ing their differentiation towards smooth muscle cells (SMC). Panels i–l show
nd phalloidin (k, l) to visualize the general outgrowth of the explants. Relative to
FGF2 (l) stimulated growth. Using phalloidin staining (m, n), mesenchymal cells
wing that FGF2 stimulates mesenchyme formation (n) compared to controls (m),
t of mesenchyme formation in the gel upon addition of different growth factors
chymal cells in gel; 2: several mesenchymal cells in the gel; 3: local extensive
gel below the entire explant. Although BMP2 did not neutralize the stimulation
F2 (m–o). The scale bar in panels a, b, e–g, i–k, and m is 100 μm and, in panels
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molecular mechanisms that direct the differentiation into the
different lineages and define the borders between the lineages.
BMPs and FGFs have been implicated in the differentiation of
cardiomyocytes in the heart-forming region and in the
formation of epicardium-derived mesenchyme and the subse-
quent differentiation of coronary vessels (Lough and Sugi,
2000; Morabito et al., 2001; Schultheiss and Lassar, 1999;
Wessels and Perez-Pomares, 2004). To unveil a possible
involvement of BMPs and FGFs in the developmental decision
of pericardial mesodermal cells to differentiate into theFig. 5. The expression patterns of BMPs and FGFs at the level of the proepicardium
pericardial mesoderm differentiating towards the myocardial or epicardial lineage. Em
sections (b–k, o, p), immunohistochemistry (a, l, m, q) or RT-PCR (n). Each expressio
of the proepicardium is outlined using a dotted line in panels l, m, o–q. Panels e1 and
seemingly complementary expression patterns of BMP2 and BMP4. FGF2 and FGF4
to FGF2 expression in the extracellular matrix of the proepicardium. Panel m shows th
the remainder of the myocardium of the heart (arrow in m). Panels o–q are neighbori
proepicardium immediate adjacent of the IFT myocardium (o) (arrows). Comparing p
q. As this difference might be due to the differences in fixation of the tissue, an RT-P
(PE), but hardly in the heart, and FGF4 mRNA in the heart but not in the PE at HH16.
autofluorescence of the tissue, as a result of the fixation of the tissue. Abbreviationsmyocardial or epicardial lineage, we first established the
expression patterns of BMPs and FGFs at the level of the
proepicardium in vivo. BMP2 (Figs. 5c, e1) and BMP5 (Fig. 5f)
are expressed in the most distal myocardium of the IFT (Figs.
5a, b) extending slightly into the base of the proepicardium.
BMP4 is expressed in the proepicardium complementary to
BMP2 and extends slightly into the distal IFT myocardium (Fig.
5d, e2). BMP6 is not expressed in this region (Fig. 5g). BMP7
(Fig. 5h) and FGF4 (Fig. 5m) are expressed throughout the
entire heart in the myocardium, although FGF4 tapers off
towards the distal myocardial border of the IFT (arrow in Fig.in HH16 chicken embryos suggest a role in the developmental decisions of the
bryos were analyzed using non-radioactive in situ hybridization on sagittal serial
n pattern is summarized in schematic drawing. For the sake of clarity, the border
e2 are enlargements of the boxed area in panels c and d, respectively, to show the
showed typical punctuated expression (l, m, q). The arrowhead in panel l points
at FGF4 expression is lower in the most distal IFT myocardium than throughout
ng sections that show the overlapping BMP2 (p) and FGF2 (q) expression in the
anels l and q shows a remarkably green fluorescence of the myocardium in panel
CR analysis was performed. Panel n shows FGF2 mRNA in the proepicardium
Therefore, the staining of myocardium found in panel q is mostly probably due to
: IFT, inflow tract; PE, proepicardium. Scale bar: 100 μm.
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of the IFT only (Figs. 5i, j). FGF2 and FGF10 are expressed in
the proepicardium (Figs. 5k, l). Because patterns of expression
of FGF2 and FGF4 were immunohistochemically determined,
we performed a RT-PCR analysis to confirm that FGF4 is
expressed in the HH16 chicken heart, and that FGF2 is
expressed in the proepicardium (Fig. 5n). The expression
patterns of all analyzed BMPs and FGFs, except for BMP6, in
the proepicardial region are suggestive of a role in the regulation
of the differentiation of pericardial mesodermal cells towards
the myocardial or the epicardial lineages.
Myocardium formation at the IFT is induced by BMP2 and
BMP4
To evaluate whether BMPs have a role in directing
proepicardial cells into the myocardial lineage, we cultured
the proepicardial explants in the presence of increasing amounts
of a natural BMP inhibitor, Noggin. Noggin was found to
inhibit, rather than to block, myocardium formation even at
1000 ng/ml. To better access the level of inhibition, we
measured the area occupied by MF20-positive cells in the
cultures. In control cultures, the myocardial area increases
during the course of the experiment (Figs. 2a′–d′). It has to be
considered that after 5 days of culture, these measurements are
likely to be an underestimate because of the multilayered nature
of the myocardial center. Cultures supplemented with increas-
ing amounts of Noggin showed a concomitant decrease of the
myocardial area (Fig. 6a). The observation that the formation of
myocardium could not be blocked might be due to the
experimental set up, in which Noggin was added to the cultures
after allowing the explants to attach to the collagen gel during
an overnight incubation. To test this possibility, we equilibrated
the collagen gels with Noggin. Also using this condition, we
found it impossible to prevent myocardium from being formed
(Fig. 6a), suggesting that in addition to BMP, at least one other
growth factor is involved in the formation of myocardium in
proepicardial explant cultures or that the proepicardium
comprises a subpopulation of cells that is already specified to
the myocardial lineage. This latter conclusion is in line with our
earlier observations on serum-free culture of proepicardia.
Because our in vivo analysis had shown that BMP4 is
expressed in the proepicardium, and BMP2 and BMP5 are
expressed in the base of the proepicardium, and in the IFT
myocardium, we tested whether these commercially available
BMPs are capable of influencing myocardium formation in
vitro. The amount of myocardium was significantly less when
the proepicardial explants were cultured in the presence of
BMP5 (Fig. 6b). Supplementing either BMP2 or BMP4 to
proepicardial explant cultures, however, increased the amount
of myocardium formed (Fig. 6b). Whereas increasing the BMP2
concentration did not result in an increase in the amount of
formed myocardium (data not shown), supplementing 50 ng/ml
of both BMP2 and BMP4 did result in an significant increase in
the amount of formed myocardium compared with 50 ng/ml of
BMP2 (Figs. 3e′ and 6b), suggesting that BMP2 and BMP4
utilize different signal transduction pathways. When the gel wasconditioned with BMP2, however, most of the cells were found
to be cardiomyocytes (Fig. 3f′). BMP2 or BMP4 added to
serum-free proepicardial cultures induced myocardium forma-
tion in the epithelial monolayer (Fig. 3d′).
The findings that BMP4 is a potent stimulator of
myocardium formation in vitro and in vivo is expressed in the
proepicardium proper suggest that BMP4 activity needs to be
tightly controlled to prevent proepicardial cells from differen-
tiating into cardiac muscle cells in vivo. Interestingly, when
proepicardia were cultured in the presence of Noggin not only
myocardium formation but also smooth muscle cell and
mesenchyme formation was inhibited (Figs. 4e, o). Although
BMP4 is, thus far, the only known BMP to be expressed in the
proepicardium proper, culturing proepicardia in the presence of
BMP4 (or BMP2) did not increase γSMA-expression or the
number of mesenchymal cells in the collagen gel (Fig. 4o and
not shown). In addition, BMP4 (or BMP2) did not induce
mesenchyme formation in serum-free proepicardial cultures
(not shown). Taken together, these observations suggest that a
yet unknown BMP is required to stimulate epicardial differen-
tiation, or that BMPs are necessary but not sufficient to promote
differentiation of proepicardial cells into the epicardial lineage
in vitro.
Proepicardium formation is induced by FGF2
To explore whether FGF signaling is involved in the
regulation of the differentiation of proepicardium into the
myocardial or epicardial lineages, we cultured proepicardia in
the presence of FGF2, 4, 8, or 10. In contrast to FGF4, 8, and
10, addition of FGF2 showed a general increase in the size of
the proepicardial culture (Fig. 4k), suggesting stimulation of
proepicardial cell proliferation. In line with earlier studies
(Dettman et al., 1998; Morabito et al., 2001), we also
observed that FGF2 increased the number of mesenchymal
cells in the collagen gel (Figs. 4n, o) and triggered the
formation of mesenchymal cells in serum-free cultures (not
shown).
Proepicardial cultures maintained in the presence of either of
the FGF Receptor-1 (FGFR-1) inhibitors SU5402 or SU4984
(Calbiochem; Mohammadi et al., 1997) remained small (Fig.
4j), and mesenchymal cells were not formed in the collagen gel
(Fig. 3h), suggesting that FGF2 signaling through FGFR-1
stimulates proliferation and mesenchyme formation in proepi-
cardial explants. Close examination of the mesenchymal cells
that were formed in cultures treated with FGF2 showed that they
were relatively small and thin and did not protrude deep into the
collagen gel (Fig. 4n). Staining these explant cultures for γSMA
showed that γSMA expression was decreased (Fig. 4f),
suggesting that differentiation into smooth muscle cells was
inhibited by FGF2.
FGF2 prevents myocardium formation in the proepicardium
Although FGF2 stimulated growth of proepicardial
cultures in general, the amount of cardiomyocytes formed
was not significantly different from control cultures (Fig. 6c)
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(Fig. 6g). In cultures supplemented with FGF8, on the other
hand, the amount of myocardium formed was significantlydecreased (Fig. 6e). When proepicardia were cultured on
collagen gels that were preconditioned with FGF4 (Fig. 6d),
8 (Fig. 6e), or 10 (Fig. 6g) the amount of myocardium
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amount of myocardium formed was even less when the gels
were preconditioned with FGF2 (Fig. 6c). Addition of either
of the FGFR-1 inhibitors did not prevent the formation of
myocardium in the proepicardial culture (Fig. 3h′), indicat-
ing that signaling through the FGFR-1 is not required for
myocardium formation.
Coexpression of BMP2 and FGF2 prevents myocardial and
epicardial differentiation
During development, BMP and FGF signaling are frequently
found to cooperate in lineage decisions (Alsan and Schultheiss,
2002; Kudoh et al., 2004; Niswander and Martin, 1993;
Thesleff and Mikkola, 2002; Warren et al., 2003; Weaver et al.,
2000). To explore whether FGF and BMP signaling also
cooperate during the differentiation of pericardial mesoderm,
we evaluated the effect of combining various FGFs and BMPs
on myocardial and epicardial differentiation. We first analyzed
the combined effect of BMP2 or BMP4 together with FGF2 or
FGF10 because of their overlapping expression domains (Fig.
5). Addition of FGF10 blunted the stimulatory effect of both
BMP2 and BMP4 (Fig. 6g). Addition of FGF2 to proepicardial
cultures supplemented with BMP4 resulted also in a block of
the stimulatory effect of BMP4 (Fig. 6c). Addition of FGF2 to
proepicardial cultures supplemented with BMP2 resulted not
only in neutralization of the stimulatory effect of BMP2 but in a
significant lower amount of myocardium formed compared to
control cultures (Fig. 6c), suggesting a synergistic inhibition of
myocardium formation by FGF2 and BMP2. This effect was
even more dramatic when collagen gels were preconditioned
with FGF2 and BMP2, resulting in a complete block in
myocardium formation (Figs. 3g′ and 6c). Also epicardial
differentiation was affected by combining BMP2 and FGF2.
Although the inhibitory effect of FGF2 on smooth muscle cell
differentiation and the stimulating effect of FGF2 on prolifer-
ation were not altered in cultures treated with both BMP2 and
FGF2 (not shown and 4l, respectively), the stimulatory effect of
FGF2 on mesenchyme formation was neutralized (Fig. 4o).
The position of the border between the myocardium and
pericardial mesoderm is regulated by FGF8
During the set-up of the proepicardial explant cultures, we
had observed that myocardium formation was more pronounced
when proepicardia were explanted on 300 μl (=standard) then
on 500 μl collagen gels (Fig. 6a). Because we had observed that
the formation of myocardium in explant cultures is dependent
on BMPs, we investigated whether a differential BMP activityFig. 6. The effects of BMPs, FGFs, and their combination on myocardium formation
as the absolute area in mm2 occupied by the myocardial (MF20-positive) cells after 5
green bars on 500 μl collagen gel. Light blue bars represent the result of cultures in wh
that the growth factor was present from the start of culture. The error bars indicate t
analyzed per condition is indicated in the base of the bar. A star indicates a significa
h shows a schematic model of myocardial and epicardial differentiation from the peric
observations. The green area identifies the myocardial differentiation zone (myoc diff
yellow area the non-differentiation/transition zone. See text for description.in the cultures on 300 μl and 500 μl collagen gels would
underlie the difference in the extent of myocardium formation.
For this, proepicardia were cultured on 300 μl and 500 μl
collagen gels in the presence of different amounts of the BMP
inhibitor Noggin. Noggin reduced the myocardial area in both
cultures to approximately the same level (Fig. 6a), though a
higher concentration of Noggin was required using 300 μl
collagen gels. Based on these findings, we inferred that the
larger amount of myocardium formed on 300 μl collagen gels is
due to a higher intrinsic BMP activity.
Because we have shown that BMPs and FGFs cooperate in
epicardial and myocardial formation, we evaluated whether the
tested growth factors had different effect in a high (300 μl
collagen gels) or low (500 μl collagen gels) intrinsic BMP
activity environment. Although the amount of cardiomyocytes
formed on 500 μl collagen gels was less than on 300 μl collagen
gels, the effects of the tested growth factors were similar, except
for FGF8. FGF8 stimulated the formation of myocardium in low
intrinsic BMP activity cultures (Fig. 6f), and inhibited the
formation of myocardium in high intrinsic BMP activity
cultures (Fig. 6e). The finding that the effect of FGF8 on
myocardium formation depends on the level of BMP activity
was underscored by the observations that addition of BMP2
plus BMP4 to cultures on 500 μl collagen gels (low BMP
activity), blunted the stimulatory effect of FGF8 response (Fig.
6f). In high intrinsic BMP activity cultures (300 μl collagen
gel), FGF8 was found to neutralize the effects of additionally
supplemented BMP2 or BMP2 plus BMP4 (Fig. 6e). Together
with the observation that FGF8 is expressed in the most distal
IFT myocardium, these findings point to a role of FGF8 in
regulation the position of the myocardial–pericardial border at
the IFT of the heart.
BMP4 and FGF4 promote the differentiation into smooth
muscle cells
At the proepicardial stage, FGF4 is expressed throughout the
entire heart and strongly decreased in the BMP2-expressing
distal myocardium of the IFT (Fig. 5m). Although myocardium
formation in proepicardial explants cultured on gels precondi-
tioned with FGF4 was decreased to a level equal as observed
with Noggin (Fig. 6d), FGF4 was not found to significantly
influence the stimulating effect of BMP2 on myocardium
formation (Fig. 6d). These observations suggest that unlike
FGF8, FGF4 is not involved in the regulation of the
myocardial–pericardial border at the IFT of the heart.
When FGF4 was combined with BMP4, the amount of
myocardium formed was strongly reduced (Fig. 6d). The effect
of FGF4 and BMP4 on myocardium formation was comparablein proepicardial explant cultures. The extent of myocardium formation is shown
days of culture. Blue bars represent explants cultured on 300 μl collagen gel and
ich the collagen gels was preconditioned with the respective growth factor, such
he standard error of the mean and the number of independent explants cultures
nt difference (P < 0.05) compared to control, unless indicated differently. Panel
ardial mesoderm adjacent to the IFTof the heart, based on the in vitro and in vivo
zone), the red area the proepicardial differentiation zone (PE diff zone), and the
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However, when the gels were preconditioned with BMP4 and
FGF4, they were not found to completely block myocardium
formation like was observed for the BMP2 and FGF2
combination (Fig. 6d). Evaluating the effect of FGF4 and
BMP4 on the recruitment of proepicardial cells into the
epicardial lineage showed that expression of the smooth muscle
marker γSMA was more extensive (Fig. 4g).
Sinus venosus restrains the formation of epicardium
Our in vitro analysis, thus far, unveiled the cardiomyogenic
potential of proepicardial cells, and furthermore, that IFT
myocardium produces factors that stimulate differentiation of
proepicardial cells into myocardial cells. The combination of
these two properties might underlie why the epicardium isFig. 7. Intrinsic differences between myocardial compartments modulate epicard
proepicardial explant (PE) recombined with a ventricular explant (VE) (a and b) or
day of culture (b and e). Staining these cultures for cytokeratin (red) and MF20 (g
ventricle (arrow in c″), whereas only individual cytokeratin-positive cells had pop
absence (c′) or to the presence (f′) of myocardium in the proepicardial portion ofinitially formed at the dorsal side of the heart and
subsequently envelops the heart in anterior and posterior
direction, rather than forming from posterior to anterior, i.e.,
from IFT to OFT. Phrased in another way, the primitive
epicardial cells need to avoid the cardiogenic signals of the
IFT until they are irreversibly committed to the epicardial
lineage. To test this hypothesis, we isolated the sinus venosus
and the apex of the ventricle of HH16 chicken embryo and
positioned an isolated proepicardium against these two
different “naked” sources of myocardium (Figs. 7a, d).
Inspecting these cocultures by light microscopy, we observed
that the proepicardium adhered to ventricular myocardium
more efficiently than to sinus venosus myocardium. Immuno-
fluorescent staining of the formed aggregates after 1 day of
culture showed that an epithelial cytokeratin-positive sheet of
cells had formed over the initially ‘naked’ ventricularium formation. Panels a, b, d, and e show bright field micrographs of a
a sinus venosus (SV) (d and e) at the start of the culture (a and d) and after 1
reen) showed that a cytokeratin-positive epithelial sheet had formed over the
ulated the sinus venosus myocardium (arrow in f″). Arrowheads point to the
the aggregates. Scale bar: 100 μm.
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cytokeratin-positive cells were found on the sinus venosus
myocardium (Figs. 7e, f). In addition, MF20-positive cells
were observed in the proepicardial part when attached to the
sinus venosus (arrow in Fig. 7f′) but not when attached to the
ventricle (arrow in Fig. 7c′). These data suggest an intrinsic
difference between sinus venosus and ventricular myocardium,
preventing or allowing epicardium formation, respectively.
Discussion
The proepicardium is a transient structure formed from the
mesothelial lining of the pericardial mesoderm adjacent to the
IFT myocardium and gives rise to the epicardium, the coronary
vasculature and cardiac fibroblasts, which we refer to as the
epicardial lineage for the sake of clarity. Culture of a
proepicardium on a thick collagen gel revealed the formation
of myocardium besides differentiation along the epicardial
lineage. This myocardium might be the result of de novo
differentiation of proepicardial cells into cardiomyocytes or the
result of proliferation of a contamination of the closely adjacent
IFT myocardium during the isolation of the proepicardium. To
discriminate these two options, we analyzed 51 proepicardia for
the presence of cardiomyocytes directly after isolation and
found that 80% did not contain any cardiomyocyte, whereas all
143 proepicardia cultured for 5 days contained a large field of
cardiomyocytes, indicating that these cardiomyocytes are
formed by differentiation. This notion is further substantiated
by the observation that BrdU blocked the formation of
myocardium in cultures of proepicardia, which is comparable
to the block in differentiation of cardiac progenitor cells from
HH5 by BrdU (Montgomery et al., 1994). Secondly, we showed
that the mesothelial lining of the proepicardium is able to
differentiate into myocardial cells, and thirdly, that the
intracellular myosin-staining patterns found in the proepicardial
cultures are characteristic for myocardial differentiation. These
findings seem to be unexpected because quail–chicken chimera
and retroviral labeling experiments had never identified a
contribution of proepicardial cells to the myocardium in vivo.
Nevertheless, our findings are consistent with fate-mapping
experiments in Xenopus, chicken, and zebrafish that suggested
that the region with myocardial potency, the heart field, extends
beyond the cells actually contributing to the formed heart
(Cohen-Gould and Mikawa, 1996; Lee et al., 1994; Raffin et al.,
2000; Serbedzija et al., 1998). Overexpression of the cardiac-
enriched transcription factors Nkx2.5 and Nkx2.3 in Xenopus
(Cleaver et al., 1996) and zebrafish (Chen and Fishman, 1996)
resulted in slightly larger hearts but not in the development of
ectopic ones, also suggesting that a region of the embryo near
the heart has properties that predispose it to a myocardial fate.
In addition, we show γSMA-positive cells and mesenchyme
in the proepicardial explant cultures, which are indicative for
differentiation into the epicardial lineage. High γSMA
expression, however, is not found in mesenchyme that has
formed in the gel but rather in scattered epithelial cells at the
periphery of the culture. These scattered epithelial cells do not
seem to migrate into the collagen gel possibly indicating thatthis is not a true epithelium-to-mesenchyme transformation. In
the mesenchymal cells in the collagen gel, a low level of γSMA
expression is found that may reflect the relatively undifferen-
tiated state of the newly formed (pro)epicardial-derived
mesenchymal cells in vivo (Pérez-Pomares et al., 2002).
Our explant assays show that the proepicardium, which does
not express myocardial (this study) or smooth muscle markers in
vivo (Landerholm et al., 1999), has the potential to differentiate
into cells of the myocardial and epicardial lineages in vitro,
indicating that the proepicardium is composed of precursor
pools of cells that are restricted to either the epicardial or
myocardial lineage, or one multipotential precursor pool of cells,
which has the capacity to differentiate into both the myocardial
and epicardial lineage. Data, thus far, are in favor of the latter
possibility because of the following observations. Analysis of
the expression pattern of myocardial markers (MF20 and
SERCA2a) in combination with a pericardial/epicardial marker
(cytokeratin) showed coexpression in the pericardial mesoderm
adjacent to both the IFT myocardium and the proepicardium
proper. The far majority of all cells in proepicardial explants
differentiate into cardiomyocytes, when the collagen gels are
preconditioned with BMP2 (Fig. 3f′), whereas Landerholm and
colleagues had shown that the majority (if not all) of
proepicardial cells can differentiate into smooth muscle cells
(Landerholm et al., 1999). Classical fate map studies have
shown colocalization of the precursors of myocardial, endocar-
dial, and epicardial cells in early mouse and chicken embryos
(Garcia-Martinez et al., 1993; Tam et al., 1997). And, in
addition, fate map studies using the Cre/Lox system have also
revealed a common origin of the myocardium, endocardium and
epicardium (Saga et al., 2000; Stanley et al., 2002).
The multipotency of the proepicardial cells raises the
intriguing question about the identity of the molecular
mechanisms that direct the pericardial mesodermal cells into
the myocardial or epicardial lineages and define the border
between the two developing lineages. The differentiation into
the myocardial or epicardial lineage seems to be mediated by an
extrinsic, inductive mechanism, which is determined by the
position of the precursor cells in the pericardial mesoderm. We
show that BMP2, 4, 5, 7, and 10, FGF2, 4, 8, and 10, are
expressed in the region of the IFT of the heart during the
development of the proepicardium, suggesting a possible
involvement of these BMPs and FGFs in this process. Since
proepicardial cells still possess the multipotential characteristics
of the pericardial lining, i.e., differentiation towards the
myocardial and epicardial lineages, our explant assay provides
a unique model to study the involvement of these factors in the
molecular mechanisms controlling the developmental switch of
the mesodermal cells lining the pericardial cavity into the
epicardial or myocardial lineage. We determined the effect of
the growth factors on myocardium formation in the in vitro
assay by measuring the myosin-positive area. Although the
initial appearance of cardiac muscle cells in the proepicardial
cultures is established by differentiation, we do not know
whether the subsequent increase in myocardial tissue is the
result of differentiation or proliferation. The presence of
individual cells with immature myosin organization around
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are the result of differentiation. In the myocardial center, which
is comprised of mostly elongated and aligned myocytes
containing linearly organized myosin, proliferation is likely to
contribute to the increase of the myocardial area after the initial
cardiac muscle cells have formed by differentiation. BrdU
staining indeed shows that proliferation contributes to the
increase of the myocardial center (data not shown). Compared
with the myocardial center, the individual immature myocardial
cells around the myocardial center, however, shows far less
BrdU staining, suggesting that indeed differentiation rather than
proliferation accounts for the formation of these myocardial
cells. Addition of BMP2 results in an increase in the myocardial
area (Fig. 3f′). The amount of individual myocardial cells in
these cultures has greatly increased, suggesting that BMP2-
stimulated differentiation accounts for the increase in myocar-
dial area, rather than stimulation of proliferation. The overall
number of cells remains similar in these cultures. On the other
hand, addition of FGF2 results in a decrease in the myocardial
area. The amount of individual myocardial cells in these
cultures has diminished, whereas the overall number of cells has
increased, suggesting that FGF2 inhibits the differentiation of
myocardial cells and not the proliferation. We are, however, not
able to determine the exact contribution of differentiation or
proliferation to the amount of formed myocardium. Together,
these observations suggest an opposite role for FGF2 and the
FGFR-1 in cardiomyocyte formation at the IFT of the heart then
in the heart-forming regions (Barron et al., 2000; Lough et al.,
1996; Zhu et al., 1999).
Based on the in vivo expression patterns and the effects of
the respective growth factors on myocardial and epicardial
cell formation in the in vitro explant assay, the region
adjacent to the IFT myocardium can be divided into three
zones (Fig. 6h): (1) the myocardial differentiation zone
expressing BMP2, 4, 5, 7 and 10 and FGF4 and 8, (2) the
epicardial differentiation zone expressing BMP4, FGF2 and
10 and (3) the transition zone or precursor zone expressing
BMP2, 4, and 5, FGF2 and 10 (Fig. 5). We would like to
propose the following developmental mechanism to underlie
the elongation of the forming heart tube at its posterior side
and the concomitant formation of the proepicardium (Fig. 6h).
In the transition zone, pericardial mesodermal cells are
exposed to myocardial differentiation-stimulating signals
BMP2 and BMP4 and start the cardiac program, as evident
from the low but significant expression of myosins and
SERCA2a. However, due to the combination of FGF2 and
BMP2, further differentiation into the myocardial or epicar-
dial lineage is strongly suppressed.
In the myocardial differentiation zone, i.e., in the absence
of FGF2, BMP2 and BMP4 drive the pericardial mesodermal
cells into the myocardial lineage which is evidenced by the
expression of myosins and SERCA2a. A negative feedback
loop in this region is provided by FGF8, of which its action
depends on the level of local BMP activity, thereby regulating
the positioning of the myocardial border. A role for FGF8 has
also been proposed in cardiomyocyte formation from
precardiac mesoderm in the heart forming region (Alsanand Schultheiss, 2002) and from the secondary heart field
(Waldo et al., 2001).
In the epicardial differentiation zone, i.e., in the absence of
BMP2, FGF2 stimulates recruitment of pericardial mesodermal
cells into epicardial-lineage, although subsequent smooth
muscle cell differentiation is inhibited. A comparable role for
FGF2 has been described in hematopoiesis, where FGF2
sustains the proliferation of hematopoietic progenitor cells
while maintaining their primitive phenotype (Kashiwakura and
Takahashi, 2005). BMP4, on the other hand, is not sufficient but
might be necessary for epicardial differentiation. Both FGF2
and FGF10 prevent formation of myocardium. Due to the
enlargement of the proepicardium and its inability to attach to
the sinus venosus myocardium, it becomes in contact with the
myocardium of the dorsal side of the heart. Due to this direct
contact between the proepicardium and the myocardium of the
heart, the BMP4 and FGF2-expressing proepicardial cells
become exposed to FGF4, which further stimulates its
differentiation along the epicardial lineage, as well as inhibits
the option to form cardiomyocytes (Fig. 4h).
Currently, we are testing whether the proposed molecular
mechanism is also operational during development in vivo by
implanting growth factor loaded beads, and secondly, we are
establishing the molecular change during the transition from
proepicardium to epicardium and its derivates. Progressively
restricted expression of either of the receptors or of a component
of downstream signalling molecules required for myocardial
differentiation throughout development may play a role in the
developmental restriction of the cardiomyogenic ability when
proepicardial cells differentiate towards the epicardial lineage.
If we map out the intersecting molecular genetic pathways that
regulate the differentiation of proepicardial cells into epicardial
cells and are, therefore, responsible for the loss of the potential
to differentiate into cardiomyocytes, we may ultimately find
epicardium-derived cells, i.e., the cardiac fibroblasts, a rich
source of progenitor cells to be clinically manipulated in order
to regenerate a wide array of impaired structures and functions
in the ailing heart, including the formation of myocardium.
Acknowledgments
We thank Dr. John Burch for the stimulating and helpful
discussion during the preparation of the manuscript, and Sabina
Tesink-Taekema for the invaluable experimental help. This
work was financially supported by the following grants: “The
Netherlands Heart Foundation Grant M96.002” (to M.J.B.vdH.,
A.F.M.M.), NWO 901-28-131 (to B.P.T.K., M.J.B.vdH), NHS-
99.168 (to B.P.T.K., M.J.B.vdH) NIH-HL33756 (to A.W.), and
NIH- HL52813 (to A.W.), PIO31159/ISCIII and NATO LST.
CLG 980429 (to J.M.P.P.).
References
Alsan, B.H., Schultheiss, T.M., 2002. Regulation of avian cardiogenesis by Fgf8
signaling. Development 129, 1935–1943.
Barron, M., Gao, M., Lough, J., 2000. Requirement for BMP and FGF signaling
during cardiogenic induction in non-precardiac mesoderm is specific,
transient, and cooperative. Dev. Dyn. 218, 383–393.
521B.P.T. Kruithof et al. / Developmental Biology 295 (2006) 507–522Brand, T., 2003. Heart development: molecular insights into cardiac
specification and early morphogenesis. Dev. Biol. 258, 1–19.
Buckingham, M., Meilhac, S., Zaffran, S., 2005. Building the mammalian heart
from two sources of myocardial cells. Nat. Rev. Genet. 6, 826–835.
Cai, C.L., Liang, X., Shi, Y., Chu, P.H., Pfaff, S.L., Chen, J., Evans, S., 2003.
Isl1 identifies a cardiac progenitor population that proliferates prior to
differentiation and contributes a majority of cells to the heart. Dev. Cell 5,
877–889.
Chacko, S., Joseph, X., 1974. The effect of 5-bromodeoxyuridine (BrdU) on
cardiac muscle differentiation. Dev. Biol. 40, 340–354.
Chen, J.N., Fishman, M.C., 1996. Zebrafish tinman homolog demarcates the
heart field and initiates myocardial differentiation. Development 122,
3809–3816.
Cleaver, O.B., Patterson, K.D., Krieg, P.A., 1996. Overexpression of the tinman-
related genes XNkx-2.5 and XNkx-2.3 in Xenopus embryos results in
myocardial hyperplasia. Development 122, 3549–3556.
Cohen-Gould, L., Mikawa, T., 1996. The fate diversity of mesodermal cells
within the heart field during chicken early embryogenesis. Dev. Biol. 177,
265–273.
Dettman, R.W., Denetclaw Jr., W., Ordahl, C.P., Bristow, J., 1998. Common
epicardial origin of coronary vascular smooth muscle, perivascular
fibroblasts, and intermyocardial fibroblasts in the avian heart. Dev. Biol.
193, 169–181.
Eggermont, J.A., Wuytack, F., Verbist, J., Casteels, R., 1990. Expression of
endoplasmic-reticulum Ca2(+)-pump isoforms and of phospholamban in pig
smooth-muscle tissues. Biochem. J. 271, 649–653.
Eisenberg, C.A., Eisenberg, L.M., 1999. WNT11 promotes cardiac tissue
formation of early mesoderm. Dev. Dyn. 216, 45–58.
Garcia-Martinez, V., Alvarez, I.S., Schoenwolf, G.C., 1993. Locations of the
ectodermal and nonectodermal subdivisions of the epiblast at stages 3 and 4
of avian gastrulation and neurulation. J. Exp. Zool. 267, 431–446.
Hamburger, V., Hamilton, J.L., 1951. A series of normal stages in the
development of the chick embryo. J. Morphol. 88, 49–92.
Han, Y., Dennis, J.E., Cohen-Gould, L., Bader, D.M., Fischman, D.A., 1992.
Expression of sarcomeric myosin in the presumptive myocardium of chicken
embryos occurs within six hours of myocyte commitment. Dev. Dyn. 193,
257–265.
Kashiwakura, I., Takahashi, T.A., 2005. Fibroblast growth factor and ex vivo
expansion of hematopoietic progenitor cells. Leuk. Lymphoma 46,
329–333.
Katus, H.A., Hurrell, J.G., Matsueda, G.R., Ehrlich, P., Zurawski Jr., V.R.,
Khaw, B.A., Haber, E., 1982. Increased specificity in human cardiac-myosin
radioimmunoassay utilizing two monoclonal antibodies in a double
sandwich assay. Mol. Immunol. 19, 451–455.
Kelly, R.G., 2005. Molecular inroads into the anterior heart field. Trends
Cardiovasc. Med. 15, 51–56.
Kelly, R.G., Brown, N.A., Buckingham, M.E., 2001. The arterial pole of the
mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm.
Dev. Cell 1, 435–440.
Kruithof, B.P., Van Den Hoff, M.J., Tesink-Taekema, S., Moorman, A.F., 2003a.
Recruitment of intra- and extracardiac cells into the myocardial lineage
during mouse development. Anat. Rec. 271A, 303–314.
Kruithof, B.P., van den Hoff, M.J., Wessels, A., Moorman, A.F., 2003b. Cardiac
muscle cell formation after development of the linear heart tube. Dev. Dyn.
227, 1–13.
Kruithof-de Julio, M., Labruyere, W.T., Ruijter, J.M., Vermeulen, J.L.,
Stanulovic, V., Stallen, J.M., Baldysiak-Figiel, A., Gebhardt, R., Lamers,
W.H., Hakvoort, T.B., 2005. The RL-ET-14 cell line mediates expression of
glutamine synthetase through the upstream enhancer/promoter region. J.
Hepatol. 43, 126–131.
Kudoh, T., Concha, M.L., Houart, C., Dawid, I.B., Wilson, S.W., 2004.
Combinatorial Fgf and Bmp signalling patterns the gastrula ectoderm
into prospective neural and epidermal domains. Development 131,
3581–3592.
Landerholm, T.E., Dong, X.R., Lu, J., Belaguli, N.S., Schwartz, R.J.,
Majesky, M.W., 1999. A role for serum response factor in coronary
smooth muscle differentiation from proepicardial cells. Development
126, 2053–2062.Lee, R.K., Stainier, D.Y., Weinstein, B.M., Fishman, M.C., 1994. Cardiovas-
cular development in the zebrafish: II. Endocardial progenitors are
sequestered within the heart field. Development 120, 3361–3366.
Lough, J., Sugi, Y., 2000. Endoderm and heart development. Dev. Dyn. 217,
327–342.
Lough, J., Barron, M., Brogley, M., Sugi, Y., Bolender, D.L., Zhu, X., 1996.
Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogen-
esis in non-precardiac embryonic mesoderm. Dev. Biol. 178, 198–202.
Manner, J., 1999. Does the subepicardial mesenchyme contribute myocardio-
blasts to the myocardium of the chick embryo heart? A quail–chick chimera
study tracing the fate of the epicardial primordium. Anat. Rec. 255,
212–226.
Meilhac, S.M., Esner, M., Kelly, R.G., Nicolas, J.F., Buckingham, M.E., 2004.
The clonal origin of myocardial cells in different regions of the embryonic
mouse heart. Dev. Cell 6, 685–698.
Mjaatvedt, C.H., Nakaoka, T., Moreno-Rodriguez, R., Norris, R.A., Kern,
M.J., Eisenberg, C.A., Turner, D., Markwald, R.R., 2001. The outflow
tract of the heart is recruited from a novel heart-forming field. Dev.
Biol. 238, 97–109.
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B.K.,
Hubbard, S.R., Schlessinger, J., 1997. Structures of the tyrosine kinase
domain of fibroblast growth factor receptor in complex with inhibitors.
Science 276, 955–960.
Montgomery, M.O., Litvin, J., Gonzalez-Sanchez, A., Bader, D., 1994. Staging
of commitment and differentiation of avian cardiac myocytes. Dev. Biol.
164, 63–71.
Morabito, C.J., Dettman, R.W., Kattan, J., Collier, J.M., Bristow, J., 2001.
Positive and negative regulation of epicardial–mesenchymal transformation
during avian heart development. Dev. Biol. 234, 204–215.
Munoz-Chapuli, R., Macias, D., Gonzalez-Iriarte, M., Carmona, R., Atencia, G.,
Pérez-Pomares, J.M., 2002. The epicardium and epicardial-derived cells:
multiple functions in cardiac development. Rev. Esp. Cardiol. 55,
1070–1082.
Niswander, L., Martin, G.R., 1993. FGF-4 and BMP-2 have opposite effects on
limb growth. Nature 361, 68–71.
Pérez-Pomares, J.M., Macias, D., Garcia-Garrido, L., Munoz-Chapuli, R., 1998.
The origin of the subepicardial mesenchyme in the avian embryo: an
immunohistochemical and quail–chick chimera study. Dev. Biol. 200,
57–68.
Pérez-Pomares, J.M., Phelps, A., Sedmerova, M., Carmona, R., Gonzalez-
Iriarte, M., Munoz-Chapuli, R., Wessels, A., 2002. Experimental studies on
the spatiotemporal expression of WT1 and RALDH2 in the embryonic avian
heart: a model for the regulation of myocardial and valvuloseptal deve-
lopment by epicardially derived cells (EPDCs). Dev. Biol. 247, 307–326.
Raffin, M., Leong, L.M., Rones, M.S., Sparrow, D., Mohun, T., Mercola, M.,
2000. Subdivision of the cardiac Nkx2.5 expression domain into myogenic
and nonmyogenic compartments. Dev. Biol. 218, 326–340.
Rosenquist, G., de Haan, R., 1966. Migration of precardiac cells in the chick
embryo: a radioautographic study. Contrib. Embryol. 263, 111–121.
Rudy, D.E., Yatskievych, T.A., Antin, P.B., Gregorio, C.C., 2001. Assembly of
thick, thin, and titin filaments in chick precardiac explants. Dev. Dyn. 221,
61–71.
Ruijter, J.M., Thygesen, H.H., Schoneveld, O.J., Das, A.T., Berkhout, B.,
Lamers, W.H., 2006. Factor correction as a tool to eliminate between-session
variation in replicate experiments: application to molecular biology and
retrovirology. Retrovirology 3, 2.
Saga, Y., Kitajima, S., Miyagawa-Tomita, S., 2000. Mesp1 expression is the
earliest sign of cardiovascular development. Trends Cardiovasc. Med. 10,
345–352.
Schultheiss, T.M., Lassar, A.B., 1999. Vertebrate heart induction. In: Harvey,
R.P., Rosenthal, N. (Eds.), Heart Development, vol. 1. Academic Press,
Boston, pp. 51–62.
Serbedzija, G.N., Chen, J.N., Fishman, M.C., 1998. Regulation in the heart field
of zebrafish. Development 125, 1095–1101.
Somi, S., Buffing, A.A., Moorman, A.F., Van Den Hoff, M.J., 2004a. Dynamic
patterns of expression of BMP isoforms 2, 4, 5, 6, and 7 during chicken heart
development. Anat. Rec. 279A, 636–651.
Somi, S., Buffing, A.A., Moorman, A.F., Van Den Hoff, M.J., 2004b.
522 B.P.T. Kruithof et al. / Developmental Biology 295 (2006) 507–522Expression of bone morphogenetic protein-10 mRNA during chicken heart
development. Anat. Rec. 279A, 579–582.
Stalsberg, H., DeHaan, R.L., 1969. The precardiac areas and formation of the
tubular heart in the chick embryo. Dev. Biol. 19, 128–159.
Stanley, E.G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L.,
Harvey, R.P., 2002. Efficient Cre-mediated deletion in cardiac progenitor
cells conferred by a 3′UTR-ires-Cre allele of the homeobox gene Nkx2–5.
Int. J. Dev. Biol. 46, 431–439.
Stern, C., Holland, P., 1993. Essential Developmental Biology. A Practical
Approach. IRL Press/Oxford Univ. Press.
Tam, P.P., Parameswaran, M., Kinder, S.J., Weinberger, R.P., 1997. The
allocation of epiblast cells to the embryonic heart and other mesodermal
lineages: the role of ingression and tissue movement during gastrulation.
Development 124, 1631–1642.
Thesleff, I., Mikkola, M., 2002. The role of growth factors in tooth development.
Int. Rev. Cytol. 217, 93–135.
van den Hoff, M.J., Kruithof, B.P., Moorman, A.F., Markwald, R.R., Wessels,
A., 2001. Formation of myocardium after the initial development of the
linear heart tube. Dev. Biol. 240, 61–76.
van den Hoff, M.J., Kruithof, B.P., Moorman, A.F., 2004. Making more heart
muscle. BioEssays 26, 248–261.
Viragh, S., Challice, C.E., 1973. Origin and differentiation of cardiac muscle
cells in the mouse. J. Ultrastruct. Res. 42, 1–24.
Vrancken Peeters, M.P., Mentink, M.M., Poelmann, R.E., Gittenberger-deGroot, A.C., 1995. Cytokeratins as a marker for epicardial formation in the
quail embryo. Anat. Embryol. (Berl.) 191, 503–508.
Wada, A.M., Smith, T.K., Osler, M.E., Reese, D.E., Bader, D.M., 2003.
Epicardial/Mesothelial cell line retains vasculogenic potential of embryonic
epicardium. Circ. Res. 92, 525–531.
Waldo, K.L., Kumiski, D.H., Wallis, K.T., Stadt, H.A., Hutson, M.R., Platt,
D.H., Kirby, M.L., 2001. Conotruncal myocardium arises from a
secondary heart field. Development 128, 3179–3188.
Warren, S.M., Brunet, L.J., Harland, R.M., Economides, A.N., Longaker, M.T.,
2003. The BMP antagonist noggin regulates cranial suture fusion. Nature
422, 625–629.
Weaver, M., Dunn, N.R., Hogan, B.L., 2000. Bmp4 and Fgf10 play opposing
roles during lung bud morphogenesis. Development 127, 2695–2704.
Wessels, A., Perez-Pomares, J.M., 2004. The epicardium and epicardially
derived cells (EPDCs) as cardiac stem cells. Anat. Rec. A Discov. Mol. Cell.
Evol. Biol. 276, 43–57.
Wessels, A., Vermeulen, J.L., Viragh, S., Kalman, F., Lamers, W.H., Moorman,
A.F., 1991. Spatial distribution of “tissue-specific” antigens in the
developing human heart and skeletal muscle: II. An immunohistochemical
analysis of myosin heavy chain isoform expression patterns in the
embryonic heart. Anat. Rec. 229, 355–368.
Zhu, X., Sasse, J., Lough, J., 1999. Evidence that FGF receptor signaling is
necessary for endoderm-regulated development of precardiac mesoderm.
Mech. Ageing Dev. 108, 77–85.
